Stepan Co (SCL) · Oct 28, 2026 · Earnings
Beat — Adjusted EPS $0.94 vs ~$0.73 consensus; revenue $692.2M vs ~$634.3M consensus
Stepan earnings beat Q3 expectations on stronger volumes, recovering margins and early Project Catalyst savings, though cash flow remained tight.
Stepan is a specialty-chemicals producer built around surfactants and polymers, now executing Project Catalyst, a two-year operational-efficiency plan targeting roughly $100 million of pre-tax savings. The quarter materially exceeded the standing earnings bar. Adjusted EPS was $0.94 versus a published consensus of roughly $0.73, while revenue reached $692.2 million versus roughly $634.3 million expected.
| Metric | Q3 2026 | Q3 2025 | Change / expectation |
|---|---|---|---|
| Revenue | $692.2M | $590.3M | +17%; vs ~$634.3M consensus |
| GAAP diluted EPS | $0.78 | $0.47 | +66% |
| Adjusted diluted EPS | $0.94 | $0.48 | +96%; vs ~$0.73 consensus |
| Adjusted EBITDA | $66.3M | $56.2M | +18% |
| Global sales volume | — | — | +3%; organic volume +7% |
| Free cash flow | $8.2M | — | Pressured by working capital |
The improvement was operational, not just pricing. Surfactants, the core business, delivered 8% organic volume growth and a 27% increase in adjusted EBITDA, while Polymers added 3% volume growth despite a scheduled German maintenance turnaround. The filing says, “Surfactant organic sales volume was up 8% and Polymer sales volume was up 3% in the quarter.” 〔0〕
Project Catalyst is beginning to show up in earnings, but the restructuring bill remains large. Third-quarter adjusted EBITDA benefited from margin recovery, volume growth and Catalyst savings, with $5.6 million of restructuring charges and roughly 100 salaried positions, or 7% of global salaried headcount, recorded during the quarter. Year-to-date GAAP net income is still a $0.7 million loss because of $76.1 million in restructuring charges, so the clean operating recovery is clearer in adjusted results than in reported earnings.
Cash conversion is the main constraint on an otherwise strong quarter. Operations generated $29.3 million, but free cash flow was only $8.2 million after $21.1 million of capital spending and higher working-capital needs. The company also closed a previously announced $28.5 million land sale, with proceeds earmarked for debt repayment.
The outlook was maintained constructively rather than upgraded. Management still expects full-year adjusted EBITDA growth, positive free cash flow and continued deleveraging, but provided no new numerical target; that makes the quarter a meaningful execution beat, not a fresh guidance reset. The separate one-cent quarterly dividend increase to $0.405 was supportive but largely routine after 59 consecutive annual increases. 〔1〕
Bottom line: This is a genuine earnings beat that validates the early operating benefits of Project Catalyst, led by stronger surfactant demand and recovered margins. The next test is whether those gains convert into sustained free cash flow while restructuring and working-capital demands ease.
Fourth-quarter results and Project Catalyst savings update
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!